Manipulation of the intestinal microbiome-a slow journey to primetime

The modern medical education system has gradually evolved starting from 1910 incorporating the suggestions by Abraham Flexner, his public disclosure of the poor conditions at many medical schools provided a means to galvanize all the constituencies needed for reform to occur. He could say what other reformers could not, due to their links to the medical education community. But now we are again going back to a pre-Flexnerian state due to multiple reasons such as gradually diminishing importance of basic science subjects for the students, the decline in the number and quality of investigator initiated research among clinical researchers, lesser emphasis to bedside training by means of detailed clinical examination and making appropriate observation of signs to reach to a diagnosis rather than over reliance on the laboratory tests and radiological modalities for the diagnosis, poor exposure to basic clinical skills starting from college throughout residency and the trend of disrespect and absenteeism from both theoretical and clinical/practical classes. The attitude of students is just to complete their required attendance so that they are not barred from appearing in examinations. This de-Flexnerization trend and regression to pre-Flexnerian era standards, ideologies, structures, processes, and attitudes, are bound to beget pre-Flexnerian outcomes, for you get what you designed for.

[1]  A. Gasbarrini,et al.  Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis. , 2023, Journal of autoimmunity.

[2]  Xia Wu,et al.  Colonic Transendoscopic Enteral Tubing Is a New Pathway to Microbial Therapy, Colonic Drainage, and Host–Microbiota Interaction Research , 2023, Journal of clinical medicine.

[3]  T. Karlsen,et al.  The microbiota and the gut–liver axis in primary sclerosing cholangitis , 2022, Nature Reviews Gastroenterology & Hepatology.

[4]  G. Ianiro,et al.  Evaluating microbial determinants of donor efficacy to translate faecal microbiota transplantation from research to clinical practice , 2022, Gut.

[5]  P. Manghi,et al.  Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases , 2022, Nature Medicine.

[6]  Peeyush Kumar,et al.  Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial , 2022, Gut.

[7]  T. Borody,et al.  Microbial determinants of effective donors in faecal microbiota transplantation for UC , 2022, Gut.

[8]  Z. Deng,et al.  Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial , 2022, Frontiers in Cellular and Infection Microbiology.

[9]  Bo Jiang,et al.  Efficacy and safety of fecal microbiota transplantation for the induction of remission in active ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials , 2022, Annals of translational medicine.

[10]  Jana G Hashash,et al.  Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. , 2022, Inflammatory bowel diseases.

[11]  C. Pollock,et al.  Faecal Microbiota Transplantation and Chronic Kidney Disease , 2022, Nutrients.

[12]  O. Gilja,et al.  Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at three years after transplantation. , 2022, Gastroenterology.

[13]  A. Weinberger,et al.  Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial , 2021, Journal of Crohn's & colitis.

[14]  L. Fu,et al.  Gut Microbiota Dysbiosis as One Cause of Osteoporosis by Impairing Intestinal Barrier Function , 2021, Calcified Tissue International.

[15]  S. Bel,et al.  Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome , 2021, bioRxiv.

[16]  T. Hausken,et al.  Current status of fecal microbiota transplantation for irritable bowel syndrome , 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[17]  P. Hrabák,et al.  Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial , 2021, Journal of clinical medicine.

[18]  K. Garey,et al.  Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Surette,et al.  Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects. , 2021, Gastroenterology.

[20]  H. Sokol,et al.  Recipient factors in faecal microbiota transplantation: one stool does not fit all , 2021, Nature Reviews Gastroenterology & Hepatology.

[21]  J. Allard,et al.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes , 2021, European Journal of Nutrition.

[22]  E. Gomaa Human gut microbiota/microbiome in health and diseases: a review , 2020, Antonie van Leeuwenhoek.

[23]  A. Masclee,et al.  Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[24]  Yun Han Kwon,et al.  Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies , 2020, Frontiers in Immunology.

[25]  C. McKenzie,et al.  Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. , 2020, The American journal of gastroenterology.

[26]  V. Anttila,et al.  Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome , 2020, Alimentary pharmacology & therapeutics.

[27]  H. Sokol,et al.  Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study , 2020, Microbiome.

[28]  Bota Cui,et al.  Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment? , 2020, Microbial biotechnology.

[29]  Bota Cui,et al.  Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening , 2020, Protein & Cell.

[30]  O. Gilja,et al.  Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study , 2019, Gut.

[31]  A. Hart,et al.  Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease , 2019, Therapeutic advances in gastroenterology.

[32]  E. Mazzon,et al.  The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials , 2019, Cell transplantation.

[33]  T. Hausken,et al.  Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones , 2019, Nutrients.

[34]  T. Grigoryeva,et al.  Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease. , 2019, Terapevticheskii arkhiv.

[35]  W. D. de Vos,et al.  The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study , 2019, Clinical and translational gastroenterology.

[36]  R. Finn,et al.  A new genomic blueprint of the human gut microbiota , 2019, Nature.

[37]  T. Vatanen,et al.  The Super-Donor Phenomenon in Fecal Microbiota Transplantation , 2019, Front. Cell. Infect. Microbiol..

[38]  I. Tentes,et al.  Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach. , 2018, Inflammatory bowel diseases.

[39]  L. Hansen,et al.  Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study , 2018, Gut.

[40]  D. Gerding,et al.  Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  Y. Naito,et al.  Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.

[42]  R. Xavier,et al.  OP014 - Analysis of 1792 gut metagenomes reveals microbial treatment targets for inflammatory bowel disease and irritable bowel syndrome , 2018 .

[43]  G. Kaplan,et al.  Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial , 2017, JAMA.

[44]  L. Albenberg,et al.  Gut microbiota and IBD: causation or correlation? , 2017, Nature Reviews Gastroenterology &Hepatology.

[45]  G. Latella,et al.  Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis , 2017, Nutrients.

[46]  Yingwei Chen,et al.  New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease , 2017, BioMed research international.

[47]  J. Raes,et al.  The resilience of the intestinal microbiota influences health and disease , 2017, Nature Reviews Microbiology.

[48]  K. Whelan,et al.  The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS , 2017, Gut.

[49]  L. Öhman,et al.  Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs , 2017, Gut.

[50]  T. Hausken,et al.  Effects of varying dietary content of fermentable short‐chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[51]  Lisa M Bramer,et al.  Dynamics of the human gut microbiome in Inflammatory Bowel Disease , 2017, Nature Microbiology.

[52]  S. Bordenstein,et al.  Fecal Transplants: What Is Being Transferred? , 2016, PLoS biology.

[53]  Lin Chang,et al.  Development and Validation of the Rome IV Diagnostic Questionnaire for Adults , 2016 .

[54]  J. Raes,et al.  Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.

[55]  A. Keshteli,et al.  FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial , 2016, Gut.

[56]  C. Romano,et al.  Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis , 2015, Front. Immunol..

[57]  R. D'Incà,et al.  Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut , 2015, Mediators of inflammation.

[58]  L. Cigliano,et al.  Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity , 2015, PloS one.

[59]  O. Goulet Potential role of the intestinal microbiota in programming health and disease. , 2015, Nutrition reviews.

[60]  E. Zoetendal,et al.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. , 2015, Gastroenterology.

[61]  L. Laine,et al.  Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. , 2015, Gastroenterology.

[62]  M. Surette,et al.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Gastroenterology.

[63]  B. Jefferson,et al.  The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology , 2015, Critical reviews in environmental science and technology.

[64]  P. Gibson,et al.  Diets that differ in their FODMAP content alter the colonic luminal microenvironment , 2014, Gut.

[65]  K. Whelan,et al.  Mechanisms and efficacy of dietary FODMAP restriction in IBS , 2014, Nature Reviews Gastroenterology &Hepatology.

[66]  S. Rabot,et al.  Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.

[67]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[68]  Derrick W. Crook,et al.  Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  E. Goldstein,et al.  Antimicrobial Activities of Fidaxomicin , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  M. Falagas,et al.  Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. , 2012, International journal of antimicrobial agents.

[71]  A. Ford,et al.  Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[72]  Neil Stollman,et al.  Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection , 2012, The American Journal of Gastroenterology.

[73]  S. Bischoff,et al.  Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) , 2012, Digestive Diseases and Sciences.

[74]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[75]  Judy H. Cho,et al.  Recent insights into the genetics of inflammatory bowel disease. , 2011, Gastroenterology.

[76]  Xiaojing Ma,et al.  Role of Nod2 in the development of Crohn's disease. , 2009, Microbes and infection.

[77]  Stuart Johnson Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. , 2009, The Journal of infection.

[78]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[79]  M. Wilcox,et al.  Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model. , 2009, The Journal of antimicrobial chemotherapy.

[80]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[81]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[82]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[83]  P. Rutgeerts,et al.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum , 1991, The Lancet.

[84]  J. Bennet,et al.  TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORA , 1989, The Lancet.

[85]  D. Jewell,et al.  Role of the faecal stream in the maintenance of Crohn's colitis. , 1985, Gut.

[86]  A M Stephen,et al.  The microbial contribution to human faecal mass. , 1980, Journal of medical microbiology.

[87]  J. Bartlett,et al.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.

[88]  L. Brandt,et al.  Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation? , 2012, The American Journal of Gastroenterology.